Navigation Links
Researchers discover that same gene has opposite effects in prostate, breast cancers
Date:10/16/2011

Researchers at Cleveland Clinic have discovered that a gene known as an androgen receptor (AR) is found in both prostate and breast cancers yet has opposite effects on these diseases.

In prostate cancer, the AR gene promotes cancer growth when the gene is "turned on." In breast cancer, the AR gene promotes cancer growth when the gene is "turned off," as is often the case after menopause, when AR production ceases in women.

What this means is that treating prostate and breast cancers require completely opposite approaches to AR. In treating prostate cancer, the strategy should be to block AR; in breast cancer, the strategy should be to support AR production.

Researchers from Cleveland Clinic's Lerner Research Institute, including Charis Eng, M.D., Ph.D., Chair, Genomic Medicine Institute; Robert Silverman, Ph.D., and Warren Heston, Ph.D., both of the Department of Cancer Biology; focused on whether the androgen receptor (AR) molecule offers evidence of the tumor suppressor protein PTEN. The research discovered that AR inhibits PTEN expression in prostate cancer cells, but stimulates it in breast cancer cells.

The conclusions, published in the Oct. 21, 2011 issue of Oncogene, explain why prostate cancer progression is associated with increased AR expression (and a common prostate cancer treatment strategy involves blocking AR), while most breast cancers occur post-menopause, after AR production has ceased (making AR supplementation a strategy for treating breast cancer).

Dr. Eng and her colleagues have mapped the interaction between AR and PTEN in both prostate and breast cancer cells, which suggests that this interaction activates or represses subsequent gene expression depending on organ-specific cofactors. Although PTEN is a known tumor suppressor, and loss of PTEN expression has been associated with numerous cancers (including breast and prostate cancers), its regulation has not been well understood. The current data provide new information regarding PTEN regulation, and suggest that identifying regulatory cofactors will be a valuable next step in determining cancer risk, as well as potential new therapies.

"We now see how androgen affects PTEN expression and ultimately cancer," said Dr. Eng. "Our observations help explain why this prostate cancer risk can be halved by drinking red wine, which increases PTEN expression. Our data also suggest that treatment of the exact same cancer must be personalized for males and for females."


'/>"/>
Contact: Dan Doron
dorond@ccf.org
216-312-0428
Cleveland Clinic
Source:Eurekalert

Related biology news :

1. Researchers do precise gene therapy without a needle
2. Researchers explore planktons shifting role in deep sea carbon storage
3. Stanford researchers examine impact of green politics on recent national elections
4. NIH grant will allow researchers to look for viral cause of most severe form of multiple sclerosis
5. UNH researchers receive NSF grant to scale up stream ecology
6. Medical College of Wisconsin researchers show molecule inhibits metastasis
7. Researchers study agings effect on the brain
8. Notre Dame researchers report progress on compound to treat neurological diseases
9. UNH researchers: Multibeam sonar can map undersea gas seeps
10. Researchers realize high-power, narrowband terahertz source at room temperature
11. Researchers: Apply public trust doctrine to rescue wildlife from politics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... ... April 29, 2016 , ... ... fundamentals to transform technology into a viable company, CereScan’s CEO, John Kelley, joined ... Kelley, a recognized leader and mentor in the Denver area business community, shared ...
(Date:4/29/2016)... Italy , April 29, 2016 ... 5.11, the latest update to its industry-leading treatment planning ... shown that Monaco version 5.11 ... can now attain calculation speeds up to four times ... . With the industry,s gold standard ...
(Date:4/28/2016)... ... 28, 2016 , ... Connecticut Innovations (CI), the ... announced the launch of VentureClash , a $5 million global investment challenge ... looks to attract the best early-stage companies here in Connecticut, around the country ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... will hold an open house for regional manufacturers at its Maple Grove, Minnesota ... Tsugami, Okuma, Hardinge Group, Chiron and Trumpf. Almost 20 leading suppliers of ...
Breaking Biology Technology: